I
INVA
Innoviva
23.48
+0.20+0.86%Opening15:18 04/08 EDT
OPEN/PREV CLOSE23.55/23.28
TODAY RANGE23.21-23.84
VOL311.83K
MARKET CAP1.74B
52 WEEK RANGE16.52-25.15
AVG VOL (3M)773.46K
% TURNOVER0.42%
TURNOVER--
P/E (TTM)7.11
% RANGE2.71%
EPS(TTM)3.301
P/E(FORWARD)11.57
P/B1.494
BVPS15.71
DIVIDEND--
P/S4.260
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.73B
SHARES OUTSTANDING74.05M
NEXT EARNINGS05/05-05/11
FREE FLOAT73.55M
LOT SIZE1
EX-DATE09/08/2015
News
Press Releases
Financial Reports
Profile
Reuters·03/24 20:53
Innoviva Announces Annual Stockholder Meeting
Reuters·03/19 11:02
Armata Pharmaceuticals delays Q4 and full-year 2025 results announcement
Seeking Alpha·03/17 09:12
PJP: Healthcare Dashboard For March
Simply Wall St·03/11 01:20
How Investors May Respond To Innoviva (INVA) Surging EPS From Continuing Operations
Simply Wall St·03/05 00:59
Assessing Innoviva (INVA) Valuation After Strong Earnings Growth And Portfolio Expansion
TipRanks·03/02 16:19
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
Simply Wall St·03/02 08:14
Innoviva’s 2025 Earnings and NUZOLVENCE Launch Might Change The Case For Investing In Innoviva (INVA)
Simply Wall St·02/28 22:36
Is It Too Late To Consider Innoviva (INVA) After Its Strong Multi‑Year Share Price Run?
Simply Wall St·02/27 19:39
Innoviva (INVA) One Off Gain Driven 65.9% Margin Challenges Bullish Earnings Narratives
Simply Wall St·02/26 18:38
Innoviva’s NUZOLVENCE Approval And Buyback Reframe Growth And Valuation Story
Same Industry
Name/Symbol
Change%
Price